Robert E. Gagnon Verastem, Inc. (VSTM) insider trading activity

Robert E. Gagnon is Director of Verastem, Inc.. Currently has a direct ownership of 34,193 shares of VSTM, which is worth approximately $257,473. The most recent transaction as insider was on May 14, 2022, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.2K

0.82% 3M change

24.83% 12M change

Total Value Held $257,473

Robert E. Gagnon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2022	BUY Grant, award, or other acquisition	-	50,000 Added 7.6%	607,880 Common Stock
Mar 21 2022	SELL Open market or private sale	$1,789 $1.27 p/Share	1,409 Reduced 0.25%	557,880 Common Stock
Jan 03 2022	SELL Open market or private sale	$40,205 $2.05 p/Share	19,612 Reduced 3.39%	559,289 Common Stock
Dec 20 2021	SELL Open market or private sale	$12,478 $2.27 p/Share	5,497 Reduced 0.94%	578,901 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	148,500 Added 20.26%	584,398 Common Stock
Aug 12 2021	SELL Payment of exercise price or tax liability	$130,094 $2.87 p/Share	45,329 Reduced 9.42%	435,898 Common Stock
Dec 18 2020	BUY Grant, award, or other acquisition	-	67,925 Added 10.62%	571,635 Common Stock

Also insider at

BBLG

Bone Biologics Corp Healthcare

Director

REG

Robert E. Gagnon

Director

Needham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VSTM shares.

Notify only if

Value

Insider Trading

Get notified when an Verastem, Inc. insider buys or sells VSTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verastem, Inc.

Track Activities on VSTM

Account